Merck & Co., Inc. Faces Hundreds of Individual Fosamax Trials

Published: Sep 03, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal judge overseeing consolidated litigation against Merck & Co over jaw injuries allegedly caused by the osteoporosis drug Fosamax has ordered hundreds of cases be dispersed to courts across the country for trial. The decision by U.S. District Judge John Keenan in Manhattan marks an unusual and potentially costly development for Merck. Companies often find it easier to reach settlements in mass tort cases that are consolidated before one judge.

Help employers find you! Check out all the jobs and post your resume.

Back to news